微创颅内血肿清除术治疗高血压脑出血的效果分析

目的:探讨微创颅内血肿清除术在高血压脑出血治疗中的应用效果。方法:选择我院收治的80例高血压脑出血患者(2014年12月至2015年12月),通过随机数字表将其分为实验组和对照组。在患者知情同意基础上,实验组患者(42例)采用微创颅内血肿清除术进行治疗,而对照组患者(38例)使用开颅血肿清除术进行治疗。观察并比较两组患者治疗前后颅内压、GCS评分(格拉斯哥昏迷评分)、神经功能,同时对两组患者治疗有效性以及安全性进行评价。结果:治疗前,两组患者颅内压、神经功能以及GCS评分无明显差异性(P0.05),而治疗后,实验组患者上述指标值明显优于对照组,且差异性明显(P0.05)。实验组患者总有效率明显高于对照组(P0.05),而不良反应发生率却低于对照组(P0.05)。结论:颅内血肿清除术治疗高血压脑出血不仅能有效降低颅内压,改善患者神经功能及其昏迷症状,并且安全性较高。

A Study on the Effect of Minimally Invasive Removal of Intracranial Hematoma on the Patients with Hypertensive Cerebral Hemorrhage

Objective:To study the application value of minimally invasive removal of intracranial hematoma on the patients with hypertensive intracerebral hemorrhage.Methods:80 cases with hypertensive intracerebral hemorrhage who were treated in our hospital from December 2014 to December 2015 were selected as the research object and divided into the experimental group and control group. There were 42 patients treated with minimally invasive removal of intracranial hematoma in the experimental group, while 38 patients in the control group were treated with craniotomy. Before and after treatment, the effects were observed and compared between the two groups of patients in the intracranial pressure, nerve function, GCS score, with evaluating the efficacy and safety in these two groups.Results:Before treatment, there was no significant difference between two groups in the intracranial pressure, nerve function and GCS score (P>0.05). After treatment, the index value stated above in the experimental group were significantly better than those of the control group(P<0.05). In addition, the total efficiency of experimental group was significantly higher than that of the control group (P<0.05), and the incidence of adverse reaction was lower than that of the control group (P<0.05).Conclusion:Minimally invasive removal of intracranial hematoma could not only effectively reduce the intracranial pressure, but also improve the neurological function and coma symptoms with high safety.